Clin2
NCT06984861Possibly a fitRecruiting

Reduced radiation with chemo for HPV-related throat cancer

Oropharyngeal Carcinoma

Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.

This trial tests if giving less radiation along with chemotherapy is safe and effective for people with HPV-positive throat cancer. It aims to reduce side effects while still controlling the cancer.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
74 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have HPV-positive throat cancer (in the tonsil, base of tongue, or back of throat) that has spread to lymph nodes.
  • You have a tumor that can be seen on a scan or exam.
  • You are in good enough health to walk and take care of yourself (ECOG 0-2).
  • You are 18 years or older.
  • Your blood counts, kidney, and liver function are within acceptable ranges.
  • You have not had radiation to the head or neck before.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05491512Recruiting· Phase 2
Reduced radiation with chemo for HPV throat cancer

This trial tests whether giving less radiation (while using standard chemotherapy) can treat HPV-related throat cancer effectively. It may help reduce radiation exposure while still controlling the cancer.

Basking Ridge, New Jersey
NCT07418034Not yet recruiting· Phase 2
Lower radiation doses for HPV-related throat cancer

This trial tests whether we can safely use lower doses of radiation for people with HPV-related throat cancer, while still targeting the areas that need it. The goal is to reduce side effects without lowering the chance of a cure.

NCT06563479Recruiting· Phase 3
Personalized vs. standard radiation for HPV-positive throat cancer

This trial compares a personalized, shorter course of radiation therapy to the standard longer course for people with HPV-positive throat cancer. The goal is to see if personalized treatment is just as effective while reducing side effects.

Hartford, Connecticut
NCT07178301Recruiting· Phase 2
Lower radiation dose for HPV-related throat cancer

This trial tests whether a lower dose of radiation to the neck is safe and effective for people with HPV-related oropharyngeal cancer. It may reduce side effects while still treating the cancer.

Chicago, Illinois
NCT06554158Recruiting
Lowering radiation for low-risk HPV throat cancer patients

This trial tests whether giving less radiation after surgery is safe and effective for people with early-stage HPV-related throat cancer. It aims to reduce side effects while still controlling the cancer.

Washington D.C., District of Columbia
NCT05268614Recruiting· Phase 2
Risk-based reduced chemo and radiation for HPV throat cancer

This trial tests whether using a lower intensity (reduced) chemo-radiation plan can work for some people with HPV-related oropharyngeal (throat) cancer without losing effectiveness. It may help reduce side effects while still controlling the cancer.

Gainesville, Florida

Hear when a new Oropharyngeal Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.